Growth Metrics

Core Laboratories (CLB) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to $14.5 million.

  • Core Laboratories' Net Income towards Common Stockholders rose 2070.03% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year increase of 10447.99%. This contributed to the annual value of $32.2 million for FY2024, which is 2384.16% up from last year.
  • According to the latest figures from Q3 2025, Core Laboratories' Net Income towards Common Stockholders is $14.5 million, which was up 2070.03% from $10.7 million recorded in Q2 2025.
  • Core Laboratories' 5-year Net Income towards Common Stockholders high stood at $23.0 million for Q2 2023, and its period low was -$8.6 million during Q4 2023.
  • Moreover, its 4-year median value for Net Income towards Common Stockholders was $7.6 million (2022), whereas its average is $7.4 million.
  • Examining YoY changes over the last 5 years, Core Laboratories' Net Income towards Common Stockholders showed a top increase of 22148.36% in 2023 and a maximum decrease of 24301.34% in 2023.
  • Core Laboratories' Net Income towards Common Stockholders (Quarter) stood at $6.0 million in 2022, then tumbled by 243.01% to -$8.6 million in 2023, then skyrocketed by 187.05% to $7.5 million in 2024, then soared by 92.76% to $14.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at $14.5 million for Q3 2025, versus $10.7 million for Q2 2025 and $69000.0 for Q1 2025.